US launches trade investigation into Germany over drug pricing, raising threat of new pharma tariffs

Reuters—The Trump administration opened a formal trade investigation into Germany's pharmaceutical pricing policies, a move that could lead to new tariffs on German drug imports. The probe targets Germany's system of negotiating lower drug prices, which American pharmaceutical companies have long complained disadvantages US-made medicines. The investigation is separate from the broader EU tariff negotiations and marks an escalation in US-European trade tensions.

• Reuters — US launches trade investigation into Germany over drug pricing - Reuters
• The Local Germany — US launches trade probe on Germany over pharma pricing
• Wall Street Journal — WSJ reported the probe could lead to new tariffs on German pharmaceutical imports
• Bloomberg — US launched a tariff probe into Germany over its pharmaceutical drug pricing policies
• France 24 — US launches Germany pharma pricing probe, raising threat of new tariffs
• CNBC — The investigation targets Germany's system of negotiating lower prescription drug prices